When completing difficult tasks, the brain requires faster delivery of energy sources (oxygen and glucose) via the blood. There is evidence to suggest that some nutritional supplements may increase blood circulation in the brain which can result in improved task performance. The purpose of the study is to evaluate the effects of a multivitamin/mineral preparation (containing a range of vitamins and minerals as contained in commonly consumed multivitamin/minerals available off the shelf) in healthy females on cerebral (brain) blood flow and energy expenditure during cognitive task performance.
Vitamins, minerals and CoQ10, exert a number of physiological effects directly relevant to energy supply and metabolism. Therefore it is hypothesized that the nutritional interventions in this trial will facilitate brain metabolic substrate distribution and utilisation during demanding brain activities with a potential benefit on task performance. This pilot, double-blind, placebo controlled, 3-arm parallel groups trial will utilise two concomitant non-invasive techniques: * Near Infrared Spectroscopy (NIRS) and * Indirect Calorimetry (ICa). The NIRS will be utilised to measure the rate of delivery of metabolic substrates (via cerebral blood flow i.e. concentrations of total-haemoglobin) and oxygen extraction from the blood (concentration of deoxy-haemoglobin) in the frontal cortex of the brain during cognitive tasks. The ICa calculated from exhaled gas analysis will be utilised to quantify the overall 'energy' costs of performance of tasks in terms of oxygen uptake, carbon dioxide production, energy expenditure, and substrate (fat and carbohydrate) metabolism. Cognitive tasks of differing levels of difficulty will be utilised with the hypothesis that energy expenditure parameters and blood flow/oxygen extraction will increase with rising task demands, and that any treatment related effect will be more evident under conditions of increased neural activity. The effects on the above mentioned parameters of two multivitamin/multimineral preparations (MMP) will be compared to placebo subsequent to single dose administration (acute) and following daily administration over an eight week period (chronic). The nutritional interventions are expected to improve nutritional status and thereby facilitate energy supply and metabolism and to have positive impact on the study parameters. The effects of the nutritional interventions on nutritional status will be evaluated by measuring the plasma/serum concentrations of a selected subset of analytes. It is hypothesized that the nutritional status at baseline and after eight week supplementation period will have an impact on metabolic substrate conversion, oxygen utilisation, cerebral blood flow and cognitive performance.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Enrollment
106
Brain performance and nutrition research centre, Northumbria university
Newcastle upon Tyne, Tyne and Wear, United Kingdom
Concentration change in oxygenated hemoglobin (Near Infrared Spectroscopy)
Time frame: 1 hour post dose
Fat oxidation (Indirect calorimetry)
Time frame: 1 hour post dose
Concentration change in deoxygenated hemoglobin (Near Infrared Spectroscopy)
Time frame: 1 hour post dose
Concentration change in total hemoglobin (Near Infrared Spectroscopy)
Time frame: 1 hour post dose
Concentration change in oxygenated hemoglobin (Near Infrared Spectroscopy)
Time frame: 56 days post dose
Concentration change in deoxygenated hemoglobin (Near Infrared Spectroscopy)
Time frame: 56 days post dose
Concentration change in total hemoglobin (Near Infrared Spectroscopy)
Time frame: 56 days post dose
Carbohydrate oxidation (Indirect calorimetry)
Time frame: 1 hour post dose
Total energy expenditure (Indirect calorimetry)
Time frame: 1 hour post dose
Fat oxidation (Indirect calorimetry)
Time frame: 56 days post dose
Carbohydrate oxidation (Indirect calorimetry)
Time frame: 56 days post dose
Total energy expenditure (Indirect calorimetry)
Time frame: 56 days post dose
Serial 3 subtractions accuracy (Computerised cognitive task)
Time frame: 1 hour post dose
Serial 3 subtractions accuracy (Computerised cognitive task)
Time frame: 56 days post dose
Serial 7 subtractions accuracy (Computerised cognitive task)
Time frame: 1 hour post dose
Serial 7 subtractions accuracy (Computerised cognitive task)
Time frame: 56 days post dose
Serial 17 subtractions accuracy (Computerised cognitive task)
Time frame: 1 hour post dose
Serial 17 subtractions accuracy (Computerised cognitive task)
Time frame: 56 days post dose
3-back task accuracy (Computerised cognitive task)
Time frame: 1 hour post dose
3-back task reaction time (Computerised cognitive task)
Time frame: 1 hour post dose
3-back task accuracy (Computerised cognitive task)
Time frame: 56 days post dose
3-back task reaction time (Computerised cognitive task)
Time frame: 56 days post dose
Stroop task accuracy (Computerised cognitive task)
Time frame: 1 hour post dose
Stroop task reaction time (Computerised cognitive task)
Time frame: 1 hour post dose
Stroop task accuracy (Computerised cognitive task)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 56 days post dose
Stroop task reaction time (Computerised cognitive task)
Time frame: 56 days post dose
Subjective rating of task difficulty for Serial 3 subtractions (Computerised Visual Analogue Scale)
Time frame: 1 hour post dose
Subjective rating of task difficulty for Serial 7 substractions (Computerised Visual Analogue Scale)
Time frame: 1 hour post dose
Subjective rating of task difficulty for Serial 17 substractions (Computerised Visual Analogue Scale)
Time frame: 1 hour post dose
Subjective rating of task difficulty for 3 back task (Computerised Visual Analogue Scale)
Time frame: 1 hour post dose
Subjective rating of task difficulty for stroop task (Computerised Visual Analogue Scale)
Time frame: 1 hour post dose
Subjective rating of task difficulty for Serial 3 subtractions (Computerised Visual Analogue Scale)
Time frame: 56 days post dose
Subjective rating of task difficulty for Serial 7 subtractions (Computerised Visual Analogue Scale)
Time frame: 56 days post dose
Subjective rating of task difficulty for Serial 17 subtractions (Computerised Visual Analogue Scale)
Time frame: 56 days post dose
Subjective rating of task difficulty for 3 back task (Computerised Visual Analogue Scale)
Time frame: 56 days post dose
Subjective rating of task difficulty for stroop task (Computerised Visual Analogue Scale)
Time frame: 56 days post dose
Subject ratings of energy levels (Computerised Visual Analogue Scale)
Time frame: 1 hour post dose
Subject ratings of energy levels (Computerised Visual Analogue Scale)
Time frame: 56 days post dose
Subject ratings of calmness (Computerised Bond-Lader mood scales)
Time frame: 1 hour post dose
Subject ratings of calmness (Computerised Bond-Lader mood scales)
Time frame: 56 days post dose
Subject ratings of contentedness (Computerised Bond-Lader mood scales)
Time frame: 1 hour post dose
Subject ratings of contentedness (Computerised Bond-Lader mood scales)
Time frame: 56 days post dose
Subject ratings of alertness (Computerised Bond-Lader mood scales)
Time frame: 1 hour post dose
Subject ratings of alertness (Computerised Bond-Lader mood scales)
Time frame: 56 days post dose